JUN 03, 2016 08:17 AM PDT

Phage therapy for C. difficile?

WRITTEN BY: Kerry Evans
Clostridium difficile loves to infect the gut, and these infections (CDIs) can be nasty and difficult to treat. These spore-forming bacteria are often resistant to antibiotics and grow within a protective pseudomembrane in the gut where they cause diarrhea and colitis.

University of Leicester researchers recently reported on the successful use of a bacteriophage cocktail to treat CDI. This technique, often called “phage therapy”, uses bacteriophages to infect and kill pathogenic bacteria without harming the human host.
 
Phage therapy could be used to treat CDIs.
(Side note.) The idea of phage therapy has been around for quite some time. Bacteriophages were first described in the early 1900s, and the Eliava Institute opened in Georgia (the country) in 1923 to research phage therapy. In fact, phage therapy is widely used in a number of European countries, but it has not caught on in the US.

(Back to your regularly scheduled programming.) The University of Leicester group tested various phages for their ability to kill (lyse) C. difficile in vitro. The phages lysed 86% of the clinical C. difficile strains tested. Specifically, the phages were effective against 12 of the 13 most common strains found in the UK.

Then they tested their phage cocktails - mixtures of phages in various combinations - in a hamster model of CDI. They found that certain cocktails reduced the bacterial load in the intestinal lumen by 4 logs and in intestinal tissues by 2 logs.

This is great, except that most of the hamsters still had relatively large amounts of the bacteria in their guts even after phage treatment. The point is, yes, the phage cocktails definitely reduced the overall bacterial burden, but they did not “cure” the animals of the infection.

Essentially, phage therapy bought the animals a bit more time. The animals were sacrificed once they reached a predetermined experimental endpoint (once their body temperature dropped to a certain point, for example). For untreated animals, this was after about 60 hours. However, animals treated with the phage cocktail took about twice as long to reach the same endpoint.

Phage therapy isn’t a cure-all (at least not for CDI). But, it could put a chink in C. difficile’s armor, helping clinicians combat these potentially deadly infections. According to M. Scott Salka, CEO of AmpliPhi Biociences (the company that funded this study), “the prevalence of C. difficile, the high costs of infection control, and the challenge of finding alternative treatments all contribute to the significant clinical and financial burden that CDI imposes on healthcare systems. The positive outcomes of these studies validate phage-based therapy as a promising approach that has the potential to address the growing challenge of CDI.”

Sources: Antimicrobial Agents and Chemotherapy, MedicalXpress, Wikipedia
 
About the Author
  • Kerry received a doctorate in microbiology from the University of Arkansas for Medical Sciences.
You May Also Like
JUL 27, 2018
Microbiology
JUL 27, 2018
Making Accurate Assessments of the Environmental Impact of Pollution
Without the right experimental design, behavioral testing can easily produce the wrong results....
AUG 08, 2018
Microbiology
AUG 08, 2018
Use of Probiotics Linked to Severe Bloating, Brain Fog
Gut bacteria can have a powerful effect on brain function....
AUG 12, 2018
Microbiology
AUG 12, 2018
What Allows Some Microbes to Live in the Gut?
Microbes have to first pass through the harsh stomach environment to colonize the gastrointestinal tract....
AUG 27, 2018
Genetics & Genomics
AUG 27, 2018
A Better Way to Classify Bacteria
The classification of organisms into groups, taxonomy, has taken an important step forward....
OCT 09, 2018
Drug Discovery
OCT 09, 2018
'Copper Antibiotic Peptide' Effective in Eradicating Tuberculosis
The bacterium responsible for Tuberculosis has found a way to avoid antibiotics by hiding inside the macrophages which are the specific immune cells that a...
OCT 11, 2018
Microbiology
OCT 11, 2018
New Vaccine Protects Against Lassa Fever and Rabies
In Africa, Lassa fever is a significant threat to public health. It is a member of the same family of viruses as Ebola....
Loading Comments...